Early and intensive motor training to enhance neurological recovery in people with spinal cord injury: trial protocol

Author:

Harvey Lisa A.ORCID,Glinsky Joanne V.,Chu JackieORCID,Herbert Robert D.,Liu HueimingORCID,Jan Stephen,Billot LaurentORCID,Scivoletto GiorgioORCID,Spooren Annemie I.,Seelen Henk A.,Ben Marsha,Tranter Keira,Chen Lydia W.,Rainey Donna,Rimmer Christine,Jorgensen VivienORCID,Di Natal Fernanda,Denis Sophie,Gollan Emilie J.,Tamburella FedericaORCID,Agostinello Jacqui,van Laake-Geelen Charlotte M.,Bell Chris,Lincoln Claire,Stolwijk Janneke M.ORCID,van der Lede Jessica,Paddison Sue,Oostra Kristine,Cameron Ian D.,Weber Gerard,Sherrington Catherine,Nunn Andrew K.,Synnott Emma-Leigh,McCaughey EuanORCID,Kaur Jasbeer,Shetty Sachin

Abstract

Abstract Study design Protocol for a multi-centre randomised controlled trial (the SCI-MT trial). Objectives To determine whether 10 weeks of intensive motor training enhances neurological recovery in people with recent spinal cord injury (SCI). Setting Fifteen spinal injury units in Australia, Scotland, England, Italy, Netherlands, Norway, and Belgium. Methods A pragmatic randomised controlled trial will be undertaken. Two hundred and twenty people with recent SCI (onset in the preceding 10 weeks, American Spinal Injuries Association Impairment Scale (AIS) A lesion with motor function more than three levels below the motor level on one or both sides, or an AIS C or D lesion) will be randomised to receive either usual care plus intensive motor training (12 h of motor training per week for 10 weeks) or usual care alone. The primary outcome is neurological recovery at 10 weeks, measured with the Total Motor Score from the International Standards for Neurological Classification of SCI. Secondary outcomes include global measures of motor function, ability to walk, quality of life, participants’ perceptions about ability to perform self-selected goals, length of hospital stay and participants’ impressions of therapeutic benefit at 10 weeks and 6 months. A cost-effectiveness study and process evaluation will be run alongside the trial. The first participant was randomised in June 2021 and the trial is due for completion in 2025. Conclusions The findings of the SCI-MT Trial will guide recommendations about the type and dose of inpatient therapy that optimises neurological recovery in people with SCI. Trial registration ACTRN12621000091808 (1.2.2021).

Funder

NSW Ministry of Health, Australia; and Wings for Life Foundation, Austria.

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3